# JAK Inhibition in Food Allergy

> **NCT05069831** · PHASE1 · COMPLETED · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 71 (actual)

## Conditions studied

- Food Allergy

## Interventions

- **DRUG:** Abrocitinib

## Key facts

- **NCT ID:** NCT05069831
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-16
- **Primary completion:** 2025-06-13
- **Final completion:** 2025-06-13
- **Target enrollment:** 71 (ACTUAL)
- **Last updated:** 2025-07-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05069831

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05069831, "JAK Inhibition in Food Allergy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05069831. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*